We are live on ! Find out more
REGN icon

Regeneron Pharmaceuticals
REGN

371 hedge funds and large institutions have $17B invested in Regeneron Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 371 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more call options, than puts

Call options by funds: $300M | Put options by funds: $263M

Holders
371
Holders Change
+371
Holders Change %
–
% of All Funds
12.11%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.29%
New
371
Increased
–
Reduced
–
Closed
–
Calls
$300M
Puts
$263M
Net Calls
+$37.1M
Net Calls Change
+$37.1M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CCMH
151
Cornerstone Capital Management Holdings
New York
$5.43M +$5.62M +24,128 New
QI
152
Quotient Investors
New York
$5.38M +$5.57M +23,904 New
HIMCH
153
Hartford Investment Management Co (HIMCO)
Connecticut
$5.22M +$5.4M +23,207 New
CTA
154
Chesley Taft & Associates
Illinois
$5.21M +$5.39M +23,168 New
HHC
155
Hutchin Hill Capital
New York
$5.12M +$5.3M +22,750 New
ASRS
156
Arizona State Retirement System
Arizona
$4.99M +$5.17M +22,200 New
SCM
157
Stevens Capital Management
Pennsylvania
$4.93M +$5.11M +21,937 New
EIM
158
ExxonMobil Investment Management
Texas
$4.77M +$4.94M +21,225 New
JG
159
Jefferies Group
New York
$4.7M +$4.87M +20,915 New
AAF
160
Andra AP-fonden
Sweden
$4.7M +$4.87M +20,900 New
KBC Group
161
KBC Group
Belgium
$4.69M +$4.86M +20,858 New
GCP
162
GSA Capital Partners
United Kingdom
$4.69M +$4.86M +20,851 New
Aviva
163
Aviva
United Kingdom
$4.63M +$4.8M +20,604 New
Alyeska Investment Group
164
Alyeska Investment Group
Illinois
$4.5M +$4.66M +20,000 New
BCM
165
Bridgeway Capital Management
Texas
$4.41M +$4.56M +19,600 New
FCAM
166
F&C Asset Management
United Kingdom
$4.41M +$4.56M +19,590 New
BF
167
BOK Financial
Oklahoma
$4.3M +$4.46M +19,137 New
ERSOT
168
Employees Retirement System of Texas
Texas
$4.27M +$4.42M +19,000 New
CCM
169
Cupps Capital Management
Illinois
$4.19M +$4.34M +18,644 New
LBG
170
Lloyds Banking Group
United Kingdom
$4.19M +$4.34M +18,632 New
PNC Financial Services Group
171
PNC Financial Services Group
Pennsylvania
$4.17M +$4.32M +18,543 New
Royal London Asset Management
172
Royal London Asset Management
United Kingdom
$3.98M +$3.95M +16,976 New
OTPPB
173
Ontario Teachers' Pension Plan Board
Ontario, Canada
$3.95M +$4.09M +17,566 New
CCM
174
Catapult Capital Management
New York
$3.93M +$4.07M +17,480 New
NG
175
NatWest Group
United Kingdom
$3.9M +$4.04M +17,337 New
5 6
7
8 9

REGN Hedge Fund Activity: Q2 2013 in Review

371 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Regeneron Pharmaceuticals (REGN) for Q2 2013, worth a combined $17B.

Buyers outnumbered sellers: 371 funds opened new REGN positions and 0 closed out — a net gain of 371 holders — while 0 added to existing stakes and 0 trimmed.

  • 371 institutional investors held Regeneron Pharmaceuticals (REGN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17B of Regeneron Pharmaceuticals stock for Q2 2013.
  • 371 funds opened new Regeneron Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +371 holders.

Based on aggregated 13F filings for Q2 2013.